These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 17704361

  • 1. Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program.
    Dalla Via P, Opocher E, Pinello ML, Calderone M, Viscardi E, Clementi M, Battistella PA, Laverda AM, Da Dalt L, Perilongo G.
    Neuro Oncol; 2007 Oct; 9(4):430-7. PubMed ID: 17704361
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Visual acuity of children treated with chemotherapy for optic pathway gliomas.
    Kalin-Hajdu E, Décarie JC, Marzouki M, Carret AS, Ospina LH.
    Pediatr Blood Cancer; 2014 Feb; 61(2):223-7. PubMed ID: 23956233
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Optic glioma warranting treatment in children.
    Kaufman LM, Doroftei O.
    Eye (Lond); 2006 Oct; 20(10):1149-64. PubMed ID: 17019413
    [Abstract] [Full Text] [Related]

  • 7. Longitudinal measures of visual function, tumor volume, and prediction of visual outcomes after treatment of optic pathway gliomas.
    Kelly JP, Leary S, Khanna P, Weiss AH.
    Ophthalmology; 2012 Jun; 119(6):1231-7. PubMed ID: 22364864
    [Abstract] [Full Text] [Related]

  • 8. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
    Gnekow AK, Kortmann RD, Pietsch T, Emser A.
    Klin Padiatr; 2004 Jun; 216(6):331-42. PubMed ID: 15565548
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Visual outcome following chemotherapy for progressive optic pathway gliomas.
    Shofty B, Ben-Sira L, Freedman S, Yalon M, Dvir R, Weintraub M, Toledano H, Constantini S, Kesler A.
    Pediatr Blood Cancer; 2011 Sep; 57(3):481-5. PubMed ID: 21241008
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Feasibility and comparison of visual acuity testing methods in children with neurofibromatosis type 1 and/or optic pathway gliomas.
    Avery RA, Bouffet E, Packer RJ, Reginald A.
    Invest Ophthalmol Vis Sci; 2013 Feb 05; 54(2):1034-8. PubMed ID: 23329671
    [Abstract] [Full Text] [Related]

  • 19. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature.
    Friedrich RE, Nuding MA.
    Anticancer Res; 2016 Aug 05; 36(8):4095-121. PubMed ID: 27466519
    [Abstract] [Full Text] [Related]

  • 20. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.
    Segal L, Darvish-Zargar M, Dilenge ME, Ortenberg J, Polomeno RC.
    J AAPOS; 2010 Apr 05; 14(2):155-8. PubMed ID: 20451859
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.